Gufic Biosciences Limited — Others, 14-11-2024: Appointment

Gufic Biosciences Limited's Board has approved the unaudited financial results for the quarter and half-year ended September 30, 2024, reporting a revenue of ₹40.70 crore, net profit of ₹4.26 crore, and basic earnings per share of ₹4.25. Mr. Akshya Kumar Mahapatra has been appointed as a Non-Executive Independent Director for an initial term of five years, subject to shareholder approval. The company also restructured its Audit and Remuneration Committees following the expiry of a director's term. This update reflects strategic governance adjustments and solid financial performance, which may foster a positive outlook among investors.